Skip to main content
Clinical Trials/IRCT20081021001378N15
IRCT20081021001378N15
Recruiting
Phase 1

Evaluating the effect of prophylactic Acetaminophen in the prevention PDA (Patent Ductus Arteriosus) in premature neonates: The randomized clinical trial

Mashhad University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patent ductus arteriosus.
Sponsor
Mashhad University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Consent to participate in the study
  • Premature babies with a gestational age of less than 30 weeks
  • Premature infants without evidence of patent ductus arteriosus

Exclusion Criteria

  • Liver or kidney disease or cholestasis
  • congenital heart disease
  • Genetic disorders and congenital malformations
  • Apgar score 5 minutes less than 5
  • Difference in pre\-duct and post\-duct oxygen saturation is more than 3%

Outcomes

Primary Outcomes

Not specified

Similar Trials